Topic - Novo Nordisk
Subscribe to this topic via RSS or ATOMNovo Nordisk manufactures and markets pharmaceutical products and services. Created in 1989 through a merger of two Danish companies dating back to the 1920s, it has become one of the world's leading companies in diabetes care, where Novo Nordisk pursues research into pulmonary delivery systems; other companies, such as Medtronic, have expanded into insulin pump systems. Novo Nordisk also commands large sectors of the markets in haemostasis management, growth hormone therapy and hormone replacement therapy. - Source: Wikipedia
Related Stories
Photos
Quotations
Dandelion Health’s study, the company says, took far less time — six weeks versus five years — and was much cheaper than the Novo Nordisk study done the traditional way.
Drugs for obesity could be used as a primary prevention tool for heart attacks, new study says →
Novo Nordisk said U.S. sales of Ozempic and Wegovy — a version of the Type 2 diabetes drug approved for weight loss — drove the growth.
Oh, Ozempic: Retail analysts see little impact from weight-loss drugs →
